1. Home
  2. PCB vs CAPR Comparison

PCB vs CAPR Comparison

Compare PCB & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCB
  • CAPR
  • Stock Information
  • Founded
  • PCB 2003
  • CAPR 2005
  • Country
  • PCB United States
  • CAPR United States
  • Employees
  • PCB N/A
  • CAPR N/A
  • Industry
  • PCB Major Banks
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PCB Finance
  • CAPR Health Care
  • Exchange
  • PCB Nasdaq
  • CAPR Nasdaq
  • Market Cap
  • PCB 289.7M
  • CAPR 324.6M
  • IPO Year
  • PCB N/A
  • CAPR N/A
  • Fundamental
  • Price
  • PCB $22.10
  • CAPR $6.28
  • Analyst Decision
  • PCB Hold
  • CAPR Strong Buy
  • Analyst Count
  • PCB 2
  • CAPR 8
  • Target Price
  • PCB $22.25
  • CAPR $24.75
  • AVG Volume (30 Days)
  • PCB 26.5K
  • CAPR 1.4M
  • Earning Date
  • PCB 10-23-2025
  • CAPR 08-11-2025
  • Dividend Yield
  • PCB 3.62%
  • CAPR N/A
  • EPS Growth
  • PCB 29.75
  • CAPR N/A
  • EPS
  • PCB 2.14
  • CAPR N/A
  • Revenue
  • PCB $102,259,000.00
  • CAPR $13,392,150.00
  • Revenue This Year
  • PCB $22.59
  • CAPR N/A
  • Revenue Next Year
  • PCB $9.32
  • CAPR $6,061.53
  • P/E Ratio
  • PCB $10.33
  • CAPR N/A
  • Revenue Growth
  • PCB 9.08
  • CAPR N/A
  • 52 Week Low
  • PCB $16.00
  • CAPR $3.98
  • 52 Week High
  • PCB $22.45
  • CAPR $23.40
  • Technical
  • Relative Strength Index (RSI)
  • PCB 57.65
  • CAPR 36.33
  • Support Level
  • PCB $21.97
  • CAPR $6.17
  • Resistance Level
  • PCB $22.41
  • CAPR $7.30
  • Average True Range (ATR)
  • PCB 0.38
  • CAPR 0.43
  • MACD
  • PCB 0.05
  • CAPR -0.11
  • Stochastic Oscillator
  • PCB 73.08
  • CAPR 4.53

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: